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Abstract
Background: In Colombia, cases of Hepatitis D virus (HDV) infection have been officially described since 1985
mainly in Amerindian population from Sierra Nevada de Santa Marta (North Caribbean Coast), Uraba (North
West), and Amazon (South East). The last official report of a clinical case of HDV infection in Colombia was
registered in 2005.
Objectives: The aims of this study were to identify cases of HDV and/or Hepatitis B virus (HBV) infection in
asymptomatic Amerindians from Amazonas state, South East Colombia, and to describe the circulating viral
genotypes in this population.
Study design: The study population was recruited in 19 Amerindian communities in the Amazonas state.
Individuals over 18 years old were screened by rapid test for Hepatitis B surface Antigen (HBsAg). Blood
samples obtained from individuals positives for HBsAg in the rapid-test assay were analyzed for HBsAg,
anti-HBc, anti-HDV IgM/IgG by ELISA. The detection of HBV DNA and HDV RNA was performed by PCR
amplification. The viral genotype was determined by sequencing and phylogenetic analysis.
Results: A total of 23/861 individuals were positive for HBsAg detection by rapid test. Serological and/or
molecular markers of HDV infection were demonstrated in 43.5 % (10/23) of samples from Amerindians. The
phylogenetic analysis demonstrated the exclusive circulation of HBV subgenotype F1b of and HDV 3 in this
population.
Conclusions: A high frequency of HBV/HDV infection was found in Amerindian population from Amazonas
State, Colombia (43.5 %, 10/23). Nine cases were identified in a population of 861 asymptomatic Amerindian
individuals; one symptomatic case (with diagnosis of end-stage hepatic disease) was also identified in the
study. The circulation of HDV 3 and HBV subgenotype F1b suggests a constant flow of these viral genotypes
as a result of the interaction of the Amerindian populations from Amazon basin. Further studies are necessary
to confirm whether HBV subgenotype F1b is the prevalent in the population from South East region in
Colombia.
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Background
HDV is a defective virus, since it requires the presence of
the Hepatitis B virus (HBV) surface antigen (HBsAg) for
assembly of infectious viral particles [1]. HDV contains a
small RNA genome with a single open reading frame
(ORF) that codes for two isoforms of the delta antigen,
small delta antigen (SDAg) and large delta antigen (LDAg).
Two major specific patterns of HDV infection have been
described: co-infection and superinfection [2, 3].
In South America, predominantly in Amazon Basin,
cases of severe hepatitis and liver failure have been usu-
ally associated with HDV/HBV superinfection [4–9].
HDV infection are described in Colombia mainly in re-
gions that have been considered highly endemic for
HBV infection including Sierra Nevada de Santa Marta
(North Caribbean Coast), Magdalena (North Caribbean
Coast), Uraba (North West), Choco (Pacific Coast) and
Amazonas (South East) [10–13].
Two important studies carried out in 1991 showed a
very high prevalence of HBV infection in habitants from
Magdalena state and Amazonas States. The first study
was conducted in 4 towns (Riofrio, Santa Rosalia, Varela
and Julio Zawady towns) considering the cases of liver
failure cases reported in Magdalena state in that period.
The prevalence of HBsAg reported in the population of
these towns ranged from 9 % to 18 %. Moreover, the
antibodies anti-HDV were detected from 6 % to 63 % in
these populations [11]. The second study was conducted
in 404 Amerindian children and adolescents belonging
to the Huitoto ethnic group in Amazonas state. The
overall prevalence of HBsAg was 18 %. Cases of liver
failure were also reported in this ethnic group [14].
The last official report of a clinical case of HDV infec-
tion in Colombia was notified in Guainia State (South
East) in 2005 [15]. Since then, no new hepatitis D cases
have been reported to the surveillance system of public
health in Colombia (SIVIGILA).
The incidence of HBV infection in Amazonas state in
2010 was 7.5 times higher (27.8/100.000) than the aver-
age incidence of the country (3.7/100.000) [16]. In 2014,
an average incidence of 4.34/100.000 was reported while
an incidence of 25.2/100.000 was notified in Amazonas
state [17]. In this state, the circulation in 2011 of HDV
genotype 3 in Amerindian population was documented
[18], even though the last official report of a clinical case
of HDV infection in the country was in 2005 [15].
The aims of this study were to identify cases of HDV
and/or HBV infection in asymptomatic individuals from
Amerindian communities in the Amazonas state and to
describe the circulating viral genotypes in this population.
Results
A total of 861 asymptomatic Amerindian individuals and
1 symptomatic (with diagnosis of end-stage hepatic
disease), older than 18 years were recruited in the
Amazonas state, South East Colombia. On average
39,4 % (range 6,4 %–90 %) of the population from each
community was included in the study (Table 1).
Twenty-three individuals from 862 (2.6 %) were posi-
tive for HBsAg by the rapid test; all serum samples were
also positive for HBsAg and Anti-HBc by Elisa. The
average age of the HBV positive individuals was 32 years
(SD ± 11.2 years); the stratification by age showed that
60.8 % corresponded to individuals between 22 and
31 years old. The proportion of men (52.2 %) and
women (47.8 %) was similar.
The frequency of HBV-positive cases was compar-
able among the communities of Puerto Nariño (2.7 %;
14/513), Leticia (2.4 %; 5/203) and Tarapaca (2.7 %,
4/146) (Table 1). The 43.5 % (10/23) of these individ-
uals declared having hepatitis and/or cases of hepa-
titis in the family; 69.6 % (16/23) of the individuals
positive for HBsAg had not been vaccinated for hepa-
titis B (Table 2).
Anti-HDV antibodies (IgM or IgG) were detected in
43.5 % (10/23) of the HBsAg-positive samples. However
none were positive for antibodies anti-HDV IgM and
IgM. HBV DNA was detected in 9/23 samples and HDV
RNA in 7/23 samples. One sample was positive for both
HBV DNA and HDV RNA (Table 3).
Figure 1 shows the phylogenetic tree generated by the
Neighbor Joining method for HBV. Isolates were
grouped in the genotype F clade with bootstrap value of
81; all were classified as subgenotype F1b. Although the
bootstrap values of the clade generated for genotype F1b
is not strong, the samples (851_AMZ, 862_AMZ,
02_AMZ and 893_AMZ) were grouped in subgenotype
F1b strains reported in Peru and Brazil [19].
Regarding the HDV genotypes, the phylogenetic tree
obtained by the Maximum Likelihood method showed
that samples were grouped in the cluster of genotype 3
(bootstrap value of 99) (Fig. 2). The strains obtained
from individuals of Amerindian communities as
Nazareth (832_AMZ and 799_AMZ) and Santa Sofia
(689_AMZ) were grouped into one clade with strains re-
ported in 2007 from patients with acute liver failure in
Amazonas state [18]; this grouping shows a possible
nearest phylogenetic relationship between the strains.
The strains isolated in Naranjales (608_AMZ) and
Puerto Nuevo (1167_AMZ) communities were grouped
in a single clade, suggesting a close phylogenetic rela-
tionship between these isolates. Additionally, the strain
obtained in Ventura community (1147_AMZ) proved to
be distant from other isolates in the study; this strain
1147_AMZ was grouped with strains from Amerindians
in the Amazon basin of Brazil (EF150933 and FJ010643),
Serrania Perija (AB037949) in Venezuela and Sierra
Nevada de Santa Marta in Colombia (L22061) [3].
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Discussion
Colombia has a heterogeneous pattern for HBV infec-
tion. Although the average incidence registered in the
period 2008–2014 to the Colombian health system
(SIVIGILA) corresponds to low-intermediate endemicity
(3.11, 3.64, 3.71, 4.2, 4,38 and 4.34/100.000), some states
including Amazonas, Norte de Santander, Guaviare and
Choco have been historically highly endemic for HBV
infection [10–13,16,17].
Indeed, a very high prevalence of anti-HBc was re-
ported in 1991 in children (0–9 years old 49 %, >10 years
old 71 %) and women (61 %) population in Amazonas
state [14]. These findings strongly suggested the imple-
mentation in 1992 of the HBV vaccination program,
mainly in high-risk populations (children under 5 years).
The effectiveness of this vaccination program was evalu-
ated 8 years later and a substantially reduction of HBsAg
prevalence (60–75 % reduction) was demonstrated in
2.145 Amerindian children under 12 years from Puerto
Nariño and Leticia (Amazonas state) and Puerto Santander
and Aracuara (Caqueta State) [20].
In the present study, 23 cases of HBV infection were
identified from 862 Amerindians (861 asymptomatic and
1 symptomatic) from 19 communities of the rural area
of Puerto Nariño, Leticia and Tarapaca in Amazonas
state. A high frequency of HDV infection was observed
in HBV-infected Ameridians (43.5 %, 10/23). The
marker anti-HDV IgM was identified in 4 cases and
anti-HD IgG in 6 cases. All cases of HDV infection were
HBsAg and anti-HBc IgM positive, but negative for anti-
HBc IgM (Tables 2 and 3). No data of HBeAg marker
and liver function was available from these cases. Unfor-
tunately, no samples remained for additional analysis
then it was not possible to classify the clinical stage of
these individuals. Except, the symptomatic case that was
classified as coinfection HDV/HDV with descompen-
sated liver chirrosis and fatal outcome.
Superinfection HDV/HBV is usually confirmed by de-
tection of anti-HDV IgM in patients HBsAg positive and
anti-HBc IgM negative. However, anti-HDV IgM Abs usu-
ally persist in patients with chronic infection. Indeed, the
anti-HDV IgM is a marker of active HDV infection and a
Table 1 Study population and individuals positive for HBsAg and HDV in 19 Amerindian communities of the Amazonas state, Colombia
Municipality Amerindian community aTotal population Study population HBV positive (HBsAg) HDV positive (anti-HDV
and/or viral genome)
Tipisca 91 50 (54.9 %) 0
Puerto Rico 92 75 (81.5 %) 2 (2,6 %)
Santarem 23 10 (43.5 %) 1 (10 %)
Doce de Octubre 107 24 (22.4 %) 1 (4,1 %)
San Juan de Atacuari 159 58 (36,5 %) 3 (5,1 %) 1
Siete de agosto 155 38 (24,5 %) 1 (2,6 %)
Puerto Narino Naranjales 205 37 (18,0 %) 1 (2,7 %) 1
Puerto Esperanza 209 63 (30,1 %) 3 (4,7 %)
Veinte de julio 129 17 (13,2 %) 0
Patrulleros 54 46 (85,2 %) 1 (2,1 %) 1
Boyahuazu 95 43 (45,3 %) 1 (2,3 %) 1
Valencia 42 23 (54,8 %) 0
Ticoya 159 29 (18,2 %) 0
Total 1520 513 14 (2,7 %) 4 (28,5 %)
San Martin de Amacayacu NA 48 0
Santa Sofia NA 37 2 (2,3 %) 1
Leticia Arara 1107 33 (6,4 %) 0
Nazareth 1016 85 (20,4 %) 3 (8,1 %) 2
Total 2123 203 5 (2,4 %) 3(60 %)
Puerto Nuevo 121 109 (90 %) 1 (0,9 %) 1
Tarapaca Ventura 144 37 (25,7 %) 3 (8,1 %) 2
Total 265 146 4 (2,7 %) 3 (75 %)
Total 6559 862 23 10
aPopulation >18 years old, data obtained from the database of the Expanded Program on Immunization (EPI). NA: Not available
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predictor of treatment response as described by Meder-
acke et al. in patients with chronic hepatitis. High anti-
HDV IgM titers were described in patients with liver in-
flammatory disease while low IgG titers were related with
inactive cirrhosis. Even, anti-HDV IgM persisted over
many years in patients with progressive liver disease and
after treatment [21].
Moreover, the findings of a study carried out in
Pakistan described the profile of HDV co-infection in
169 patients from 480 cases of HBV infection with dif-
ferent clinical spectrum of disease. The AST level was
normal in 43.2 % (73/169) of the patients and 75.7 %
were negative for HBeAg. Asymptomatic carrier HBV
stage was described in 26.6 % of the patients [22].
Considering the findings of these studies and the data
of the present study, the individuals identified in these
Amerindian communities could be cases of coinfection
HDV/HBV.
HDV infection has been reported in other Amerindian
populations in the Amazon basin with variable frequen-
cies among the countries (Table 4). The overall anti-
HDV rate was 13.4 % in 7 Amerindian communities in
Brazil [23]. In Piaroas and Yanomami Amerindian com-
munities in Venezuela, anti-HDV antibodies were re-
ported in 6.4 % and 4.3 %, respectively [24]. Similarly, in
a study carried out in population from Peruvian Amazon
Basin, the prevalence of anti-HDV was 39 % [25]. A fre-
quency of 8.25 % anti-HDV antibodies was reported in
Amerindians from Amazonas state in Colombia [26].
The frequency of HDV infection found in the present
study population may be due to the bias selection of
HBV infection cases by the rapid test of HBsAg detection.
The rapid test is useful in areas like the Amazonas that
are difficult to access; although the use of this technique
probably generated a bottleneck excluding individuals
HBV infected with HBsAg levels below the detection limit
(3,5 IU HBsAg/mL) of the test [27]. Nevertheless, a high
Table 2 Socio-demographic and exposure variables of
Amerindians positive for HBsAg
Variables of study N = 23 Percent
Age group
22-31 years 14 (60,8 %)
32-41 years 6 (26,1 %)
>41 years 3 (13 %)
Gender
Female 11 (47,8 %)
Male 12 (52,2 %)
Ethnic group
Tikuna 17 (73,9 %)
Cocama 2 (8,7 %)
Yagua 4 (17,4 %)
Municipality
Puerto Narino 14 (60,8 %)
Leticia 5 (21,7 %)
Tarapaca 4 (17,4 %)
Dental extraction or healing
No 8 (34,8 %)
Yes 15 (65,2 %)
Consumption of saliva fermented drinks
No 7 (30,4 %)
Yes 16 (69,6 %)
History of viral hepatitisa
No 13 (56,5 %)
Yes 10 (43,5 %)
HBV vaccination
Incomplete 7 (30,4 %)
Complete 0 (0 %)
Unvaccinated 16 (69,6 %)
aFamiliar or individual history of viral hepatitis
Table 3 Serological and Molecular markers of HDV/HBV infection in Amerindians from Amazonas state, Colombia
Code of samples IgM anti-HD IgG anti-HD Viral genome HBsAg anti-HBc total IgM anti-HBc Viral genome
608 + - + + + - -
992a - + + + + - -
880 - + - + + - -
896 - + - + + - -
799 + - + + + - +
689 + - + + + - -
832 + - + + + - -
1137 - + - + + - -
1167 - + + + + - -
1141 - + + + + - -
aSymptomatic patient
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frequency of HDV infection in these communities is not
excluded considering the epidemiology pattern of the
HBV and HDV infection in these communities during the
last 30 years [13, 14, 16, 17, 20].
In the present study, all cases were associated with
HDV 3 (n = 7) and HBV subgenotype F1b (n = 9) (Figs. 1
and 2). This result is consistent with previous reports of
these genotypes in Amerindian populations in the
Amazon basin [3, 18, 28–31].
The non-monophyletic clustering obtained for HBV
and for HDV strains of this study, as well as the
proximity of the strains with those obtained in Peru and
Brazil, suggest that these viruses are circulating in these
populations, maybe through inter-ethnic interaction of
Amazon basin communities and could be related to dif-
ferent sources of infection.
In South America, several studies demonstrated the
predominance of HDV 3 in Amerindian population, as-
sociated mainly with HBV genotype F (subgenotypes F3
and F1b); although some cases of coinfection with HBV
genotype A and genotype D were reported [3, 6, 28, 30].
In Venezuela and in Brazil, coinfection HDV 1 with
Fig. 1 Unrooted phylogenetic tree of HBV ORF S generated by Neighbor Joining method. The sequences of this study (799, 1013, 851, 862, 817,
520, 680, 02 and893_AMZ) indicated with red circles, were compared with representative sequences of all HBV genotypes (A-I). The sequences
are denoted with the GenBank accession number, genotype, country and year in which they were reported. The tree was generated using the
software MEGA 5.1. Bootstrap values (indicated by arabic numbers) were obtained from 1000 replications. The black circle indicates the location
of the positive control
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Fig. 2 (See legend on next page.)
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HBV genotypes F and D has been described [31, 32].
Additionally, HDV 8 has been described in two cases in
Brazil [33].
The analysis of the HBV DNA sequence coding for the
S region of the envelope proteins demonstrated a phylo-
genetic relationship (862_AMZ, 851_AMZ, 02_AMZ,
893_AMZ) with subgenotype F1b isolated from individ-
uals in Peru (Fig. 1). The phylogenetic distribution of these
sequences indicates that HBV F1b circulates among
Amerindian communities of the Amazon basin, regardless
the country.
The interaction among the Amerindian communities
of the Amazon basin is very dynamic including friend-
ship, matrimonial alliances, rituals and festivals, and pol-
itical organizations [34]. Actually, the Tikuna is the main
community in Peru and in South East Colombia. Such
ties could explain the movement of these strains be-
tween the countries and the prevalence of HBV subge-
notype F1b in these populations.
However, studies in other populations in Colombia
(blood donor population and patients with end-stage
liver disease) showed the prevalence of HBV subgeno-
type F3 [35, 36]; however, none of the samples of the
present study correspond to subgenotype F3.
A recent study performed in two municipalities of
Colombia, Quibdo (Pacific Region) and Apartado (North
east region) characterized the HBV genotypes in asymp-
tomatic people with risk factors for HBV infection. The
genotype F was found in both population (subgenotype
F3 and F1a) and genotype A was only described in
Quibdo. It should be noted that the population predom-
inant in Quibdo are Afro-descendant, while in Apartado
there are different ethnic groups, including Caucasian,
Mestizo and Afro-descendants [37]. This result is in
agreement with the report of Alvarado et al. in Afro-
descendant individuals from Quibdo with a predomin-
ance of HBV subgenotype A [38].
The findings of these studies suggest that HBV geno-
type F3 is the most frequent in populations from the
Andean region of Colombia (Antioquia, Bogotá and
Bucaramanga), HBV genotype A in the Pacific region
(Quibdo) while HBV subgenotype F1b could be the pre-
dominant in South East (Amazonas state) [18, 35–38].
The circulation of different HBV genotypes could be
related to the numerous ethnic groups present in
Colombia. Indeed, the estimated admixture population
in Colombia is American ancestry 0.29, European ances-
try 0.6 and African ancestry 0.1; although African ances-
try is highest in the Pacific and Atlantic regions
(particularly on the Pacific) and the highest European
ancestry is in the central region of Colombia. Mean-
while, American ancestry is highest in the south of the
country [39].
Several limitations of this study need to be considered
which a rapid test was used for selection of the individ-
uals HBsAg positive. Importantly, the epidemiological
data was obtained only from the 23 individuals HBsAg
positive as well the blood samples. Moreover, the serum
sample was not available for liver function marker. Fi-
nally, a follow-up of the patients should be performed to
determine the clinical stage and the treatment.
In conclusion, coinfection HBV/HDV was frequent in
the study population (43.5 %, 10/23). Nine cases were
identified in a population of 861 asymptomatic Amerin-
dian individuals; one symptomatic case (with diagnosis
of end-stage hepatic disease) was also identified in the
study. The circulation of HDV 3 and HBV subgenotype
F1b in this population suggests a constant flow of these
Table 4 Studies of HDV/HBV infection frequency in Amerindian populations of Amazon basin
Reference Country Population Anti-HBc+ HBsAg+ aAnti-HD+
Cabezas C. et al, 2006 Peru 37 Amerindian Communities n = 870 59.7 % 9.4 % 39 %
Braga W. et al, 2001 Brazil 7 Amerindian communities n = 688 54.5 % 9.7 % 13.4 %
Duarte M. et al, 2010 Venezuela Piaroas n = 414 27.4 % 5.1 % 6.4 %
Yanomami n = 231 58 % 14.3 % 4.3 %
Alvarado M. et al, 2011 Colombia 4 ethnic groups n = 176 54.5 % 7.9 % 8.2 %b
a% individuals HBsAg positive
b% individuals HBcand/or HBsAg positive
(See figure on previous page.)
Fig. 2 Unrooted phylogenetic tree of the ORF Delta of HDV, generated by maximum Likelihood method. Study sequences (1147, 992, 608, 1167,
832, 799 and 689_AMZ) indicated with red circles, were compared with sequences representative of all HDV genotypes [1–8]. The sequences are
denoted with the GenBank accession number, genotype, country, acute liver failure diagnosis (FHA) and year in which they were reported. The
tree was generated using the software MEGA 5.1. The bootstrap values (indicated by arabic numerals) were obtained from 1000 replication
values. The black circle indicates the location of the positive control serum and the blue circle, the plasmid positive control
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viral genotypes in Colombia, as a result of the intra and
inter-ethnic interaction of the Amerindian population
from Amazon basin.
The findings of this study are important for public
health authorities in Colombia considering the import-
ant number of HDV/HBV cases identified in asymptom-
atic population in Amazonas state to establish a protocol
for diagnosis and management of viral hepatitis in
Amerindian population.
Further studies are necessary to confirm whether HBV
subgenotype F1b is the prevalent in Amerindians from
South East region in Colombia (Amazonas, Caqueta,
Vaupes, Guaviare and Putumayo states) and whether
other HBV genotypes have been recently introduced.
Additionally, it would be very interesting to evaluate the
HBV evolution in these Amerindian communities.
Methods
Study Area
The study area is located in the Amazonas state, South
East Colombia. This state has approximately 74.000 in-
habitants mainly Amerindians (72 %) that belong to dif-
ferent ethnic groups including Tikuna, Cocama, Yagua,
Huitotos and Muinanes [34]. The study was carried out
in 19 Amerindian communities of the rural zone of
Tarapaca Village and Puerto Nariño and Leticia
municipalities. These communities are settled on the banks
of the Putumayo River and a tributary (Cotue) (Fig. 3a) and
the Amazon River and its tributaries (Boyahuazu,
Amacayacu and Loretoyaku rivers) (Fig. 3b).
Study population
Amerindian men and women, over 18 years of age, who
voluntarily agreed to participate by signing the informed
consent, were recruited for the study between June 2011
and May 2013. The population was invited to participate
in the study through home visits and meetings in each
one of the communities.
All procedures adopted in this study were followed the
terms established by the Ethic Committee of Universidad
Nacional (N.14, Faculty of Medicine, Universidad
Nacional). The project was approved by the health au-
thorities of the Amazonas state and by the Amerindian
communities.
Serological and molecular markers of HBV infection
Rapid tests for the detection of HBsAg (HBsAg deter-
mine Orgenic Kit; Alere, USA; detection limit 3,5 IU
HBsAg/mL) were carried out on the study population.
Individuals positive by the rapid test were interviewed
by one of the researchers, who completed a demographic
questionnaire (age, gender, birthplace, Amerindian
Fig. 3 a. Map of North in Amazonas State in Colombia. Geographical location of the Amerindian communities in rural área of Tarapaca village
included in the study. b. Map of South in Amazonas State in Colombia. Geographical location of Amerindian communities in rural areas of
Puerto Nariño and Leticia municipalities included in the study
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community, municipality, ethnicity, social security and
education) and epidemiological variables (history of jaun-
dice, history of hepatitis, risk factors of viral hepatitis,
Hepatitis B vaccination status). After that, blood samples
were collected from these individuals. Serum samples
were stored at −4 °C until the time of transportation to
the laboratory. The samples were kept at −70 °C.
All serum samples were analyzed using commercial
ELISA kits for detection of HBsAg (ABBOTT PRISM
HBsAg assay, USA) and total anti-HBc (ABBOTT
HBcore PRISM assay, USA) following the manufacturer’s
instructions. The samples were analyzed in duplicate.
DNA was extracted from the serum using a commer-
cial kit (Qiagen, The Netherlands). The HBV genome
was detected by nested polymerase chain reaction
(nested-PCR) of ORF S (nt 422–758). Amplification con-
ditions and cycling were modified from protocols previ-
ously published [40, 41]. Primers used in the first round
were YS1 and YS2 [39]. The PCR conditions were 3 min
93 °C, 35 cycles 45 s 94 °C, 1 min 53 °C and 1 min 72 °C,
and 6 min 72 °C. Nested-PCR was performed using the
primers S3s and S3as [38]. The cycling conditions were
4 min 94 °C, 40 cycles 1 min 95 °C, 1 min 50 °C and
1 min 72 °C, and 7 min 72 °C.
Serological and molecular markers of HDV infection
HBsAg-positive serum samples were analyzed for anti-
HD IgM and IgG using commercial ELISA kit (HDV
IgM and IgG; DIA.PRO, Italy) following the manufac-
turer’s instructions. All samples were tested in duplicate.
Serum samples that were HDV positive for molecular/
serological markers were tested for anti-HBc IgM (Abbott
anti-HBc-IgM test; USA).
Viral RNA extraction was performed using a commer-
cial kit (QIAamp Viral RNA Mini Kit, Qiagen;
Germany). Detection of the HDV genome was per-
formed by RT-nested PCR (delta ORF nt 877–1290).
Amplification conditions and cycling were modified
from protocols previously published [3, 42]. Briefly, re-
verse transcription was performed at 37 °C for 60 min
(MMLV, Invitrogen, USA), using the primer 1302D.
Primers and conditions of the first round PCR were
8531U and 1302D, 2 min 94 °C, 40 cycles 30 s 94 °C,
30 s 56 °C and 1 min 72 °C and 10 min 72 °C. For the
second round PCR, the primers HDV-E and HDV-A
were used. The cycling conditions consisted of 4 min
94 °C, 40 cycles 1 min 95 °C, 1 min 50 °C and 1 min
72 °C, and 7 min 72 °C.
Viral genotype characterization
Nucleotide sequences of amplicons were determined by
automated dideoxysequencing (Macrogen, Inc. Seoul,
Korea). Sequences were aligned with Clustal X and edi-
ted using Bioedit 7.1.11. Unrooted neighbor-joining and
maximum-likelihood trees were constructed using the
Mega 5.1 (Molecular Evolutionary Genetics Analysis)
software. The best model of nucleotide substitution was
Kimura-2-parameter + Gamma distribution for HBV,
and model of nucleotide substitution model for HDV
corresponded to Hasegawa-Kishino-Yano + + Invariably
Gamma distribution. Reliability of the trees was evaluated
statistically by bootstrap analyses with 1000 replicates.
Bootstrap values higher than 70 % were considered signifi-
cant. Genotypes were determined according to the cluster-
ing of 49 HBV and 56 HDV sequences available from the
GenBank database (National Center for Biotechnology
Information, National Institutes of Health).
Statistical analysis
For quantitative variable the mean, median and standard
deviations were obtained. The information was tabulated
in MS Excel 2010. For statistical analyzes, the SPSS
(Statistical Product and Service Solutions) software
version 14.0 was used.
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